mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.004 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.004 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.004 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.004 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.004 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.006 |